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Permane nt intestinal failure , whe the r se condary to se ve re gastroint e stinal tract dysfunction or short bowe l syndrom e , re mains a challe nging pe diatric he alth proble m that re quire s innovative the rape utic modalitie s. Ste atorrhe a and intractable diarrhe a result in failure to thrive , hypovitaminosis, hypoprote ine mia, e le ctrolyte disturbance , and metabolic acidosis if pare nte ral alime ntation (TPN) is begun too late . A varie ty of medical and surgical tre atments have bee n de vise d to addre ss each of the unde rlying cause s of childhood inte stinal failure . None the le ss, a signi® cant pe rcentage of childre n with intestinal failure remain pe rmane ntly bound to pare nte ral nutrition. While some of the se childre n suffe r minimal morbidity, othe rs succumb to the life -thre atening complications of TPN. Until re cently the y had no hope for survival, but within the past decade small inte stinal transplantation has offe re d the m an opportunity for prolonge d life emancipate d from the shackle s of TPN.
In this re vie w, we shall discuss in de tail microvillus inclusion dise ase , inte stinal pseudoobstruction , and short bowel syndrome , which are the most common cause s of pediatric inte stinal failure coming to intestinal transplantation. The factors facilitating intestinal adaptation or predisposing to irreve rsible live r disease in childre n with short bowe l syndrome will be de scribed. We shall also enume rate the indications for pe diatric inte stinal transplantation and outline the surgical technique s, postope rative manage ment, and results of our expe rie nce to date at the Unive rsity of Pittsburgh Transplantation Institute . Finally we shall recount re cent scienti® c advance s like ly to improve patie nt survival in the future .
MICROVILLUS INCLUSION DISEASE AND INTESTINAL PSEUDOOBSTRUCTION
In 1978, Davidson e t al de scribe d ® ve Canadian infants with a speci® c form of intractable diarrhe a (1) . Four of the ® ve had a positive family history of this disorde r, and all ® ve had speci® c histologic abnormalitie s. Light microscopy of the ir small inte stine s reveale d villous atrophy but no crypt hype rplasia. Ele ctron microscopy reve aled cytoplasmic ve sicle s near the apical surface of e nte rocytes. The vesicle s possesse d microvilli and se cretory granule s. Four of the ® rst ® ve cases die d in e arly infancy. A subse que nt de taile d account (2) of 23 cases surve ye d from around the world indicate d that the disorde r had bee n se en in patie nts of Caucasian, Asian and Arab line age ; there was a 2:1 female predominance . Most patie nts presented with diarrhe a in the ® rst week of life, but rare ly it was not recognize d until 40 ± 60 days of life. Diarrhe a was profound, with most patie nts losing 200 ± 500 cc of stool per kilogram of body weight pe r day. Malabsorption of all nutrie nts was e vide nt. No pharmacologic interve ntion was e specially e ffe ctive, but pare nteral somatostatin could reduce stool output by half. Eighty percent of the childre n died during infancy with the rest bound ine xtricably to TPN. It is notable that loss of venous access for only a few hours could le ad to death from de hydration in the se patients.
Chronic intestinal pse udoobstruction is characte rize d by the signs and symptom s of intestinal obstruc-tion without anatomic obstruction (3). Case s that are not se condary to hypothyroidism , scle rode rma, amyloidosis, gastroschisis, Hirschsprung' s dise ase , or othe r disorde rs are de emed idiopathic. The two major cate gorie s of idiopathic pse udoobstruction are the ne uropathic and the myopathic forms. With e ither of the two type s, symptoms be gin at birth in 50% of patie nts and by age one ye ar in 75% . Almost half the patie nts, re gardle ss of type , have small bowel malrotation. Bilious vomiting, abdominal diste nsion, and obstipation are almost unive rsally prese nt, but paradoxically, some patie nts de velop se cretory diarrhe a. The se verity of symptoms will wax and wane during the ® rst se ve ral ye ars of illne ss. Patie nts with the ne uropathic form are more like ly to have seve re, incapacitating abdominal pain, and those with the myopathic form are at risk for spontane ous bowel pe rforation. Megacystis and megaure te r are freque nt accompanime nts. The e ntire bowe l may be involve d or the re may be se lective involve ment of the colon. In some case s the disorde rs see m to be acquire d and may progre ss from isolate d colonic involve ment to total involve ment of the alime ntary canal. Manome tric change s range from abse nt or de crease d motility in the myopathic form to high-am plitude , nonpropogate d clusters, re trograde propogation, or failure to produce a fe d patte rn in the neuropathic form. Some patie nts derive transie nt be ne® t from pharmacologic the rapy with prokine tic drugs or somatostatin, and othe rs can be fed by slow continuous e nte ral fe eding through a je junostomy or gastrostom y. The subse t of the se patie nts incapable of tole rating ade quate ente ral calorie s be cause of visceral pain, vomiting, or malabsorption is face d with the prospe ct of re ceiving TPN. Whe n TPN complications be come life-thre atening, multivisce ral transplantation is ne cessary.
SHORT BOWEL SYNDROME
Short bowe l syndrome accounts for the majority of pe diatric re ferrals for small inte stinal transplantation ( Table 1) . The most common disorde rs requiring massive inte stinal rese ction include ne crotizing ente rocolitis, midgut volvulus, gastroschisis, and conge nital small bowe l atre sias.
Following rese ction, the le ngth of the remaining bowel doe s not correlate pe rfe ctly with prognosis. One re ason is that bowe l length can not be measure d very pre cise ly. Me asure d le ngth de pe nds upon the exte nt of contraction or relaxation at any point in time. For e xample , 350 cm of bowel measure d in vivo may e xpand to 600 cm in a postmorte m examination (4) . Additionally, in¯ame d bowel unde rgoe s shorte ning postope rative ly.
O the r factors in¯uencing the prognosis of short bowel syndrom e include the ge stational age of a ne wborn at the time of small bowe l re se ction, the postnatal age of the patie nt at the time of re section, the remaining length of small bowe l afte r rese ction, the site of re maining small bowe l, the pre se nce or absence of an ileoce cal valve , the re maining length of colon afte r rese ction, and the amount of damage incurre d by the re maining gastrointe stinal tract at the time of initial insult (5) .
Duode nal re section le ads to disproportionat e malabsorption of minerals and folic acid. Jejunal rese ction disproportionat ely impairs prote in and carbohydrate absorption (6) , which can be partially ove rcome if ileal length is ade quate . Howe ver, jejune ctomy also results in decreased production of chole cystokinin and se cretin, which in turn leads to gallbladde r stasis and de creased exocrine pancre atic secretion. Inadequ ate je ju nal produc tio n of gas tric in hi bito ry polype ptide (GIP) and vasoactive inte stinal polype ptide (V IP) combine d with re duced gastrin catabolism result in increased serum gastrin and gastric hype rsecretion (7) .
Massive ileal re section not only de crease s ove rall inte stinal absorptive surface are a but also disrupts the enterohe patic circulation of bile salts, le ading to e ithe r a deple ted bile salt pool and ste atorrhe a, or bile salt-me diate d diarrhe a (8) . Absorption of vitamin B 12 may also be inade quate following exte nsive re se ction of the terminal ileum (9) . Rese ction of the ileoce cal valve shorte ns intestinal transit time and permits colonic conte nts to re gurgitate into the small bowe l, resulting in small bowel bacte rial ove rgrowth syndrome (10) .
Disaccharide intole rance fre que ntly accompanie s short bowel syndrome and othe r type s of intestinal failure . Malabsorbe d carbohydrate s are fermente d by colonic¯ora to produce short-chain fatty acids such as acetate , butyrate , and propionate (11, 12) . Among patie nts with ste atorrhe a, luminal ionize d calcium is saponi® e d by fatty acids, resulting in e xcessive fre e oxalate pre sented to the colon. Incre ase d colonic absorption of free oxalate leads to hype roxalure a, placing patie nts at risk for oxalate urolithiasis (13) .
INTESTINAL ADAPTATION
The capacity for inte stinal adaptation following massive small bowe l re section is gove rned by a varie ty of factors. In ge ne ral, childre n se em to be more capable of adapting than are adults (14 ± 19) . Successful adaptation is also facilitate d by the pre se nce of the ile oce cal valve . In his classic treatise , Wilmore (14) showe d that survival was possible among infants le ft with 15 cm of je junum and ile oce cal valve . Forty centimeters of je junum were ne cessary for survival if the ileoce cal valve had bee n sacri® ced. More re cent publications (15± 18) have de scribed survival among childre n with as little as 10 cm of re maining bowe l, but an intact ileoce cal valve re mains an important de terminant of survival.
Adaptation re sults in incre ase d villous height, inte stinal le ngth, and intestinal diame ter. Individual cellular absorptive capacity doe s not improve , but the number of cells pe r unit of surface are a incre ase s (19) . In unfe d animals, disuse villus atrophy occurs within thre e days of a rese ction, but early institution of enteral fe eding promote s re cove ry and e nhance s inte stinal adaptation.
Enterocyte s, which have the greate st ene rgy require ments of all type s, utilize glutamine in pre ference to glucose (20) . This obse rvation has le d inve stigators to study the e ffects of pare nteral or e nte ral glutam ine supple mentation upon the small bowel mucosa whe n the gastrointe stinal tract is stre ssed and the muscle glutamine pool is like ly to be de pleted. Wilmore' s group has shown that TPN-induce d mucosal atrophy in rats can be partially corrected by glutamine enrichme nt of pare nteral aminoacids (21) . An isonitroge nous quantity of glycine will have comparable effects when delive re d at 1 g/100 ml but not at 2 g/100 ml. In an animal model of short bowe l syndrome , this same group showed that alte ring the die tary compositions of an e lime ntal die t such that glutamine comprised 25% of the total amino acids re sulted in signi® cantly improve d adaptation (22) . Human studie s by this group sugge sted that substitution of othe r amino acids with an isonitroge nous quantity of oral glutam ine combine d with pharmacologic pare nte ral dose s of growth hormone could improve caloric absorption by about 20% and re duce stool output by about 25% in the limite d numbe r of adults with short bowel syndrome who were tested (23) . Animal studie s by Vande rhoof and colle ague s cast some doubt upon the salutary e ffe ct of e nte ral glutamine insofar as substitution of glycine or glucose for glutamine in isocaloric quantitie s led to comparable or bette r adaptation following 80% bowel re section (24, 25) .
Proble matic patie nts are those whose small bowe l ne ve r adapts, those who de velop chole stasis and subseque nt e nd-stage live r dise ase associate d with TPN, those with multiple te chnical line complication s, those who de ve lop seve re infe ctious and metabolic complications of TPN, and those who experience an unsatisfactory quality of life se condary to their unde rlying intestinal disorde r.
TPN-ASSOCIATED LIVER DISEASE
A varie ty of live r disorde rs may be se t patie nts bound to TPN. Fatty live r and he patic ® brosis are common in adults and olde r childre n re ceiving TPN. Those change s are linke d to the de live ry of e xcessive carbohydrate calorie s (26) . In contrast, chole stasis is commonly obse rve d among infants and younge r childre n (27, 28) . Both exoge nous (TPN-re late d) factors and individual host factors place patie nts at risk for chole stasis. The TPN-relate d factors (28) most ofte n implicate d include provision of e xcessive prote in; provision of e xcessive glycine , alanine , and tryptophan; provision of¯avinoids, which are photooxidize d to toxic products; or provision of insuf® cie nt antioxidants such as selenium or tocophe rol. Finally, re lative taurine de ® ciency may be instrume ntal in the cholestatic process.
It is well re cognize d that chole stasis begins earlie r and is more se ve re among infants re ceiving more than 2 g prote in/kg body weight/day by the pare nte ral route as compare d with counte rparts receiving # 2 g/kg/day (29) . Furthe rmore , glycine and alanine will produce a signi® cant chole static e ffe ct whe n pe rfuse d into isolate d, pe rfuse d rat live r (30) . The sulfate d amino acid tryptophan is also chole static, but its chole static effe ct is e nhance d by photooxidation to tryptophan sulfoxide (31) . Ribo¯avin se e ms not only to facilitate the photooxidation of tryptophan but also become photooxidize d to a pote ntial hepatotoxin itself (32) . Taurine is a provisionally esse ntial amino acid in premature infants, malnourishe d patie nts, or cirrhotic patie nts who do not posse ss e nough cystathionine synthe tase or S-ade nosylme thionine synthe tase to permit taurine synthe sis by trans sulfura-tion of methionine . In the case of taurine de ® cie ncy, monohydroxy bile acids are pre fe rentially conjugate d with glycine , re nde ring them more hepatotoxic than the ir taurine -conjugate d counte rparts (33) .
Host-re late d factors (34) playing a role in chole stasis are a reduction in bile acid pool due to prematurity or inte stinal bile acid wasting, the de velopme nt of biliary sludge due to prolonge d fasting or insuf® cient chole cystokinin production, the loss of portal he patotrophic factors in the abse nce of e nte ral fee ding, excessive portal ve in conce ntrations of e ndotoxin le ading to reduce d bile¯ow, or the damaging e ffects of bacterial cell wall glycoprote ins upon he patic function afte r bacte rial translocation across the intestine.
Live r abnormalitie s can be re verse d if intestinal function permits e arly initiation of enteral nutrition, minimizing the ne e d for TPN. Cycling of pare nte ral nutrition, prote cting solution from light (32) , supplementing with taurine (33) , and judiciously e mploying oral antibiotics for se le ctive bowel decontam ination (35) are all accepted therape utic strategie s. More recently animal studie s have sugge sted that prophylaxis with intrave nous ursode oxycholic acid preve nts TPN chole stasis (36) . Pilot human studie s (37, 38) sugge st that oral ursode oxycholic acid may actually reve rse chole stasis in TPN-bound patie nts. Howe ve r, a subse t of patie nts with irre versible bowe l dysfunction may de ve lop irreve rsible live r damage within months or years after TPN is starte d. Isolate d orthotopic live r transplantation may be an unwise option for them be cause the ne e d for TPN will persist, with subse que nt damage to the ne w live r. Additionally, the short se gment of re maining bowe l may not pe rmit satisfactory Roux-e n-Y biliary drainage of the allograft live r, and a duct-to-duct biliary anastomosis may be te chnically impossible .
INDICATIONS FOR SMALL BOWEL TRANSPLANTATION
In orde r to qualify for combine d small bowel± live r transplantation, the patie nt must be plague d by irreversible intestinal failure , TPN depende ncy, and endstage live r dise ase (39, 40) . Patie nts without e nd-stage live r disease but with seve re he patic ® brosis or cirrhosis are more proble matic. In this group, it may be dif® cult to judge the amount of functioning live r ne cessary to withstand the insult of portal dive rsion during small intestinal transplantation. It is also possible that a pe rsistent nee d for TPN during the ® rst fe w posttransplant weeks might lead to irreve rsible he patic damage . Thus, all such patie nts are liste d for a combine d small bowel-live r transplant; howe ver, the ® nal de cision of allograft type will like ly be made in the ope rating room afte r assessing for evide nce of portal hype rte nsion and judging the se verity of cirrhosis at the time an organ be come s available .
TPN-de pende nt patie nts without live r dise ase must also satisfy rigorous criteria be fore be ing conside red active candidate s for isolate d intestinal transplantation. The ir inte stinal dise ase must be irreve rsible , and the y must be TPN-de pende nt. Additionally, at le ast one of the following crite ria must be met: inade quate venous acce ss must imperil the ability to administe r TPN, the risk for fatal TPN complications (such as recurre nt se psis) must be substantial, or the unde rlying disease proce ss (such as microvillus inclusion dise ase or diffuse juve nile polyposis) must be lifethre atening.
SURGICAL TECHNIQUE
The abdominal viscera are analogous to a cluste r of grape s and e ach of the organs (the grape s) may be transplante d singly or in groups (41) . Two central ste ms (the celiac axis and the supe rior mesenteric artery) supply arte rial blood. These arteries can be anastomose d to the infrare nal or suprace liac aorta. V enous drainage of the small bowel± live r allograft is into the con¯ue nce of the recipie nt he patic veins, where as the isolate d small bowe l allograft can be draine d into the re cipie nt portal ve in, sple nic vein, or inferior vena cava (as a pe rmane nt mesocaval shunt) .
The donor ile ocecal valve and colon can be include d in the graft to e nhance wate r and electrolyte absorption. Figure 1 illustrate s isolate d small intestinal transplant. Figure 2 describe s small bowe l transplantation in conjunction with a live r graft. A multivisce ral graft is shown in Figure 3 .
POSTOPERATIVE CARE
Induction and mainte nance immunosuppre ssion are achie ve d using the macrolide immunosuppre ssant age nt, tacrolim us (30, 31) , which is not only 100 time s more pote nt than cyclosporine A, but is also absorbe d quite well in the uppe r gastrointe stinal tract in the abse nce of intralum inal bile acids. This age nt functions like cyclosporine to inhibit T-ce ll production of inte rle ukins 2, 3, and 4 as well as granulocyte stimulatory factor and inte rfe ron-a (42) . It produce s somewhat less hype rtension and markedly less hirsutism and gingival hype rplasia than doe s cyclosporine (43) .
The dose use d is 0.1 mg/kg/day by continuous intravenous infusion, be ginning immediate ly after re perfusion of the allograft. A whole blood le vel of 15± 20 ng/ml is de sirable . As soon as postope rative ileus resolve s, oral tacrolimus is started at a dose of 0.2 mg/kg/day and ove rlappe d with intrave nous tacrolimus for a day or two to e nsure therape utic plasma le ve ls.
Adjuvant ste roid the rapy is initiate d during the ope ration and customarily eliminate d within a fe w wee ks base d on the patie nt's clinical condition. Patients usually re ceive an intraope rative pare nte ral bolus of intrave nous hydrocortisone (300 ± 500 mg for childre n weighing le ss than 20 kg, 500 ± 1000 mg for childre n weighing more than 20 kg) followe (44) . Azathioprine is provide d at a dose of 1± 2 mg/kg/day. It is initially give n intrave nously and late r by mouth. Table  2 outline s the immunosupp ression re gime n curre ntly employe d at the Unive rsity of Pittsburgh.
MONITORING OF REJECTION
Se rum live r enzyme leve ls are measure d freque ntly, and live r biopsie s are performed pe riodically. Live r allograft rejection is monitore d just as it would be for patie nts who have unde rgone isolate d live r transplantation. Reje ction of the gastrointe stinal tract is suspe cted anytime the patie nt's clinical picture de te riorate s, stom al output in cr e ase s or de c re ase s, endoscopic examination becomes abnormal, or histologic fe ature s of reje ction appe ar. Endoscopic biopsie s can be obtaine d by e sophagogastrodu ode noscopy, stomal e ndoscopy, or colonoscopy. The se are pe rformed as freque ntly as twice a week initially or whene ver the inde x of suspicion for re jection is high. Clinical ® ndings prompting e ndoscopic e valuation are fe ver, ile us, incre ase d stoma output, or gastrointe stinal blee ding.
Endoscopically, e arly signs of re jection are ede ma, erythe ma, friability, and ape ristalsis. Progre ssion to aphthoid ulce rs and ultimate ly, broad-base d ulce rs with overlying pse udome mbrane occurs whe n immunosuppre ssion is inade quate (45, 46) . Histologic characte ristics (Figure 4 ) of intestinal acute cellular reje ction are activate d lymphocyte s attacking crypt epithe lium and patchy e pithe lial apoptosis (47) . Se vere re je ction may progre ss to desquamation and diffuse pse udome mbranous enterocolitis. Regene ration may occur in such instance s but usually afte r long, intensive courses of immunosuppre ssion (48) . Of our eight pe diatric patie nts experiencing seve re e xfoliative re jection, three unde rwent graft entere ctomy, with one be ing subse que ntly successfully re transplante d. Yet a fourth unde rwent imme - In this case the Carre l patch with the supe rior me sente ric artery and celiac axis origins has be en used to cap a free graft of donor thoracic aorta that has bee n used as a conduit. This is only one of the se veral options that the operator should be pre pare d to e xe rcise. diate live r± small bowe l re transplantation but die d afte r a disse minate d ade novirus infe ction.
Endoscopic and histologic change s may involve small bowe l, stomach, and colon simultane ously or change s may be con® ned to one anatom ic area (49) . Usually the ile um is the most se vere ly damage d region, but occasionally the je junum is prefe rentially affected.
We have identi® e d ª chronic inte stinal reje ctionº in one adult patie nt but among none of our pe diatric recipie nts (50) . That patie nt, who stoppe d his immunosuppre ssion months afte r transplantation, deve lope d a ª wasting disorde rº characte rize d by steatorrhe a. Small bowel endoscopy was normal, but patchy villous atrophy was pre se nt histologically. More impre ssive than mucosal abnormalitie s were submucosal change s, including smooth muscle hype rtrophy and vascular oblite ration, which would have bee n misse d with mucosal biopsy. Supe rior mese nte ric arteriography reve aled segmental narrowing of jejunal and ile al arteries. Eithe r full-thickne ss biopsy or angiography is thus re quire d to establish the diagnosis of chronic reje ction.
CONTROL OF REJECTION
This is achie ved by modulating immunosuppre ssive age nts to achie ve optimal le vels (39, 40) . The tacrolimus dose may be increased, a ste roid bolus may be give n, or a ste roid ª re cycleº may be initiate d. O KT3 may be use d in se vere or re fractory acute cellular reje ction.
INFECTION SURVEILLANCE AND TREATMENT
Infection control plays a ke y role in succe ss of small bowel transplantation (39, 40) . The mucosal barrie rs of native bowe l pe rmit very little translocation of bacte ria or ye ast into mesenteric lymphatics, but once the re, gut organism s are transporte d by macrophage s to re gional mese nte ric lymph node s for immunologic re cognition and surve illance . In the transplant e d bowel, this orde rly proce ss may be impaire d by immunosuppre ssion, luminal microbial overgrowth, dysfunction of gut-associate d lymphocyte s during graft repopulation by re cipie nt cells, and acute cellular reje ction. Incre ase d numbe rs of gram -ne gative aerobe s such as E. coli, Klebsiella, and Pseudom onas can translocate from gut lume n dire ctly into the portal circulation, leading to life -thre atening sepsis. Hence judicious postope rative use of antimicrobial age nts is impe rative .
Intrave nous, broad-spe ctrum antibiotics are give n for ® ve days postope rative ly and for 24 hr following endoscopic proce dure s. O ral, nonabsorbable antibiotics (including amphote ricin and an aminoglycoside ) are give n for se veral wee ks routine ly and subseque ntly whene ve r stomal gram-ne gative microbial counts e xce e d 10 8 colony forming units pe r millilite r in an e ffort to selective ly de contaminate the bowel. The purpose of selective decontamination is to reduce numbe rs of intraluminal, gram-ne gative aerobe s, the reby permitting anae robe s (which are le ss like ly to induce se pticemia) to prolife rate (51) . Pne umocystis, cytomegalovirus, and he rpes prophylaxis are accomplishe d with prophylac tic trimethoprim-sulfa , ganciclovir, and acyclovir, re spe ctively.
POSTOPERATIVE NUTRITIONAL SUPPORT
As soon as postope rative ile us re solve s, je junostomy fe eding is be gun as a continuous, low-volume infusion of age -appropriate se mielemental formulas. During the ® rst six ye ars of the program, patie nts were gene rally starte d on formulas containing thermally or enzymatically hydrolyze d cow' s milk prote in. More re cent transplant re cipie nts have initially received Tole rex, which contains glutamine . Be cause mese nte ric lymphatics compromise d at the time of transplantation may re quire se ve ral wee ks to re canalize, this low-fat formula is usually well tole rate d. Pare nte ral nutrition, which is be gun during the early postope rative pe riod, is continue d until such time as the allograft absorptive capacity is ade quate to sustain life. Notably, we have not se en signi® cant TPN-associate d he patic dysfunction in any patie nts who are also receiving enteral nutrition.
ASSESSMENT OF ALLOGRAFT ABSORPTIVE FUNCTION
Hematologic and bioche mical blood tests are performe d to asse ss the state of hydration and renal function. Stomal output, urine output, and daily body weights are meticulously re corded and se rve to guidē uid and e le ctrolyte balance . Stom al absorption testing is performed periodically to asse ss absorption of nutrie nts. Seve nty-two-hour fe cal fat balance is conducte d as soon as the diet contains substantial quantitie s of long-chain fats. Fatsoluble vitamin le vels are measure d se veral weeks afte r weaning from pare nte ral nutrition. A stable or a rising se rum albumin le ve l and improve d anthropometric measure ments and growth velocity indicate satisfactory absorption of prote ins. Daily measurement of re ducing sugars in stomal ef¯uent as well as periodic measure ment of D-xylose absorption are means of assessing carbohydrate and monosaccharide absorption. Se rum calcium, phosphorus, magne sium, iron, trace element le ve ls, and tacrolimus le ve ls while the patie nt is off pare nteral supple ments are also marke rs of graft function.
OUTCOME
Betwe en May 1990 and June 1995, 44 small bowel grafts were transplante d into 41 pe diatric patie nts age d 6 months to 18 ye ars at the Unive rsity of Pittsburgh Medical Center. Table 1 e numerate s the cause s of inte stinal failure in these patie nts. O rgans transplante d were an isolate d small bowel graft in 10 and small bowe l with live r in 27. Multivisce ral transplants including stomach and pancre as were performed in six, and one patie nt re ceive d a multivisce ral transplant without the live r. Be twee n January and June 1995, ® ve of the transplant recipie nts receive d simultane ous bone marrow infusions to enhance the e stablishme nt of chimerism. Twenty-four childre n are still alive from two months to ® ve years postope rative ly. Four of the ® ve re ceiving bone marrow have survive d for thre e to six months. As of June 1995, 21 of the 24 living childre n were off TPN and e xclusive ly on ente ral fe eding.
The pe diatric de aths were due to sepsis in four patie nts, respiratory syncitial virus (RSV ) pne umonia in two, GVHD in one , and posttransplant lymphoprolife rative dise ase (PTLD) in three , cerebral infarction in one , re je ction in four, iatroge nic salt toxicity in one , and respiratory failure after line inse rtion in one .
OBSTACLES TO SUCCESSFUL INTESTINAL TRANSPLANTATION
The succe ssful inte stinal transplant re quire s care ful atte ntion to de tail. The transplant te am should not only posse ss the technical e xpe rtise to pe rform the surge ry but also the willingne ss to provide meticulous postope rative care to the transplant recipie nt. Any succe ssful manage ment strategy must include re cognition and anticipation of pote ntial obstacle s to success. A fe w of those obstacle s will be discusse d individually.
Flu id an d Electrolyte Im balan ce
Patie nts re ceiving a small inte stinal transplant unde rgo ile ostomy to permit e asy e ndoscopic monitoring for re jection. They are thus subje ct to high output ile ostomy drainage until such time as absorption mature s. Fluids and e le ctrolyte s are initially provide d intrave nously but as inte stinal function matures, they may be de live re d e nte rally via a fee ding je junostomy. Not only is the sodium re quire ment quite substantial, but calcium and magne sium le vels must be monitore d closely and daily supple ments of each must be provide d for se veral weeks.
Rejection
Almost all patie nts e xpe rience reje ction at le ast once during the postope rative pe riod, but the spe ctrum of se ve rity is quite broad. Reje ction may be seve re and intractable , beginning with the ® rst postope rative week and progre ssing to de ath or entere ctomy de spite an intensive course of immunosuppre ssion. Conve rsely, some patie nts experience only mild, episodic asym ptomatic histologic re jection that, if le ft untre ated, may become clinically appare nt.
There fore , close e ndoscopic and histologic monitoring is imperative . It has be en our policy to perform surve illance ileoscopy twice wee kly or at the ® rst sign of clinical de terioration. Notably, gram-ne gative sepsis ofte n accompanie s re je ction. Thus, signs of se psis should not lull the clinician into e xcluding reje ction as a cause of symptoms (52) . Reje ction is patchy in distribution, usually involving the ile um, but occasionally prefe rentially involving the proximal small intestine (49) .
After se veral postope rative months, patie nts are usually quite stable and the risk for reje ction de cline s. Howeve r, viral e nte ritis occurring months or years afte r transplantation may re sult in malabsorption of tacrolim us re sulting in late -onse t re jection. Hence , a sense of vigilance must be maintaine d inde ® nitely.
Viral In fection s
Invasive cytomegalovirus (CMV ) infections continue to plague pe diatric small bowe l transplant recipie nts. As with live r transplantation, infections appe ar most fre que ntly in CMV -ne gative re cipie nts who have re ceive d a CMV -positive grafts. Infections are characte rized by he patitis and by hemorrhagic ente rocolitis. Fortunate ly, the use of prophylactic ganciclovir during the ® rst two postope rative we e ks see ms to be associate d with a re duced risk for infe ction (53) . Furthe rmore , active infe ction can be successfully tre ated without appre ciably reducing immunosuppre ssion by using a se ve ral wee k course of pare nte ral gancyclovir (54) .
In contrast, Epste in-Barr virus (EBV) infe ctions are more dif® cult to tre at. Like recipie nts of solid organs, intestinal transplant re cipie nts are prone to de velop EBV -associate d posttransplant lymphopro-life rative dise ase (PTLD), which straddle s the borde r betwe en infe ction and neoplasia (55) . The se lymphoid tumors are characte rize d by destructive lymphoid in® ltrate s, gross tumors, clonal prolife ration of lymphocyte s, and (fre que ntly) progre ssion to ne oplasia. No e ffe ctive antiviral age nt exists for PTLD. PTLD may appe ar among immunosupp re sse d organ recipie nts eithe r as a primary infection or reactivation of re mote ly acquire d dise ase . Childre n, who are more like ly to deve lop primary EBV infections, se e m to be at gre ater risk than are adults for PTLD. The risk is also e nhance d among childre n who have had re je ction se vere e nough to require high dose s of tacrolimus, multiple ste roid recycles, and O KT3. Sple ne ctomy appe ars to be an inde pe nde nt risk factor (56) . Antiviral strate gies such as treatment with acyclovir, ganciclovir, and inte rfe ron-a have bee n disappointingly unsucce ssful (42) . Like live r transplant recipients with PTLD, small bowel transplant re cipie nts with PTLD should unde rgo re duction in immunosuppre ssive dose s. Howe ve r, unlike live r transplant recipie nts, the y can not re ly upon tumor ane rgy to prote ct against re je ction if immunosuppr e ssion is discontinue d. Therapy of concommitant PTLD and rejection has bee n characte rized as ª a therape utic tightrope º whe reby aggre ssive treatment of reje ction le ads to progre ssion of PTLD and aggre ssive re duction in immunosuppr e ssion re sults in seve re re jection.
Graft-versus-Host Disease (GVHD)
The use of tacrolimus, ste roids, and azathioprine has re nde re d groundle ss the conce rn that GVHD would be a major clinical proble m among small bowel transplant re cipie nts. In the Pittsburgh se rie s, GVHD was obse rved only in rare and unusual circumstance s. One patie nt with je junal atresia and common variable immune de ® cie ncy de ve lope d GV HD soon afte r transplantation. Anothe r, who expe rie nce d seve re rejection, unde rwent removal of the allograft. Transie nt GVHD induce d by re sidual de ndritic (antige n presenting) cells deve lope d only afte r removal of the allograft and cessation of immunosupp re ssion.
Intestin al Dysm otility
A small subse t of intestinal transplant re cipie nts have unde rgone formal manome tric te sting (57) . In those patie nts examine d during fasting pe riods, antral wave s were of re duced amplitude and freque ncy. Migrating myoelectric comple xe s (MMCs) originate d in the stomachs only whe n stomach and small bowel were transplante d in continuity. When isolate d small bowel transplant was pe rforme d, MMCs originate d in the allograft and could be re trograde , ante grade , or simultane ous. No patie nt had a normal fe d patte rn. Denervation of the bowe l and use of tacrolim us, which may itse lf e ffe ct motility, were undoubte dly contributory factors. Regardle ss of these abnormalities, all patie nts tole rate d oral and enteral nutrition.
FUTURE TRENDS IN TRANSPLANTATION
Eve n though transplantation has progre sse d gre atly since its inception in 1959, the mortality rate re mains quite high and the degree of immunosuppre ssion require d re mains worrisome . Until ne wer, more re-® ned immunosuppre ssion be comes available , an effe ctive approach may be the enhance ment of syste mic chime rism (58) .
Chime rism is known to occur following intestinal transplantation. Epithe lium of the allograft is donorde rive d, but Pe ye r's patche s be come populate d by recipie nt lymphocyte s. Additionally, donor de ndritic cells are commonly e ngrafte d into distant organs of the recipie nt. The model be st e xplaining this phe nome non is the two-way mixe d lymphocyte re action, which can also occur after bone marrow transplantation if recipie nt marrow is not cytoablate d. It has bee n shown that immunologic tole rance can be conferre d afte r solid organ transplantation if chime ric environment is e nhance d by simultane ous bone marrow transplantation (58) . This rationale has gove rned our pe rformance of simultane ous bone marrow infusion and intestinal transplantation in ® ve of our most recent six inte stinal transplants. It is too early to judge the be ne® cial e ffe ct of this strate gy, but the early outcome in our small se rie s of patie nts re ceiving bone marrow± intestinal transplants has be e n quite favorable .
The ne ed for immunosuppr e ssion in the ® rst postope rative wee ks has not be en e xce ssive , and it is anticipate d that the nee d for long-te rm immunosuppre ssion will be re duce d afte r a period of time. While the technique s for producing donor± re cipie nt immunologic balance are far from perfe ct, we remain optimistic that e nhance ment of chimerism will successfully m in im iz e the ne e d for pharm acolog ic immunosuppr e ssion as well as its numerous unde sirable side effects.
